Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Deacetylation of Miro1 by HDAC6 blocks mitochondrial transport and mediates axon growth inhibition.

Kalinski AL, Kar AN, Craver J, Tosolini AP, Sleigh JN, Lee SJ, Hawthorne A, Brito-Vargas P, Miller-Randolph S, Passino R, Shi L, Wong VSC, Picci C, Smith DS, Willis DE, Havton LA, Schiavo G, Giger RJ, Langley B, Twiss JL.

J Cell Biol. 2019 Jun 3;218(6):1871-1890. doi: 10.1083/jcb.201702187. Epub 2019 May 8.

PMID:
31068376
2.

Bichaoticity induced by inherent birhythmicity during the oscillatory electrodissolution of silicon.

Tosolini A, Patzauer M, Krischer K.

Chaos. 2019 Apr;29(4):043127. doi: 10.1063/1.5090118.

PMID:
31042966
3.

Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia.

Pollyea DA, Tallman MS, de Botton S, Kantarjian HM, Collins R, Stein AS, Frattini MG, Xu Q, Tosolini A, See WL, MacBeth KJ, Agresta SV, Attar EC, DiNardo CD, Stein EM.

Leukemia. 2019 Apr 9. doi: 10.1038/s41375-019-0472-2. [Epub ahead of print]

PMID:
30967620
4.

Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib.

Stein EM, DiNardo CD, Fathi AT, Pollyea DA, Stone RM, Altman JK, Roboz GJ, Patel MR, Collins R, Flinn IW, Sekeres MA, Stein AS, Kantarjian HM, Levine RL, Vyas P, MacBeth KJ, Tosolini A, VanOostendorp J, Xu Q, Gupta I, Lila T, Risueno A, Yen KE, Wu B, Attar EC, Tallman MS, de Botton S.

Blood. 2019 Feb 14;133(7):676-687. doi: 10.1182/blood-2018-08-869008. Epub 2018 Dec 3.

5.

Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition.

Harding JJ, Lowery MA, Shih AH, Schvartzman JM, Hou S, Famulare C, Patel M, Roshal M, Do RK, Zehir A, You D, Selcuklu SD, Viale A, Tallman MS, Hyman DM, Reznik E, Finley LWS, Papaemmanuil E, Tosolini A, Frattini MG, MacBeth KJ, Liu G, Fan B, Choe S, Wu B, Janjigian YY, Mellinghoff IK, Diaz LA, Levine RL, Abou-Alfa GK, Stein EM, Intlekofer AM.

Cancer Discov. 2018 Dec;8(12):1540-1547. doi: 10.1158/2159-8290.CD-18-0877. Epub 2018 Oct 24.

6.

Editorial: Gene Therapy for the Central and Peripheral Nervous System.

Tosolini AP, Smith GM.

Front Mol Neurosci. 2018 Feb 22;11:54. doi: 10.3389/fnmol.2018.00054. eCollection 2018. No abstract available.

7.

Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis.

Tosolini AP, Sleigh JN.

Front Mol Neurosci. 2017 Dec 7;10:405. doi: 10.3389/fnmol.2017.00405. eCollection 2017. Review.

8.

The travel diaries of tetanus and botulinum neurotoxins.

Surana S, Tosolini AP, Meyer IFG, Fellows AD, Novoselov SS, Schiavo G.

Toxicon. 2018 Jun 1;147:58-67. doi: 10.1016/j.toxicon.2017.10.008. Epub 2017 Oct 12. Review.

PMID:
29031941
9.

Palaeoecology: North-South recovery divide.

Tosolini AM.

Nat Ecol Evol. 2017 Jan 4;1(1):33. doi: 10.1038/s41559-016-0033. No abstract available.

PMID:
28812557
10.

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia.

Stein EM, DiNardo CD, Pollyea DA, Fathi AT, Roboz GJ, Altman JK, Stone RM, DeAngelo DJ, Levine RL, Flinn IW, Kantarjian HM, Collins R, Patel MR, Frankel AE, Stein A, Sekeres MA, Swords RT, Medeiros BC, Willekens C, Vyas P, Tosolini A, Xu Q, Knight RD, Yen KE, Agresta S, de Botton S, Tallman MS.

Blood. 2017 Aug 10;130(6):722-731. doi: 10.1182/blood-2017-04-779405. Epub 2017 Jun 6.

11.
12.

Viral-mediated gene therapy for spinal cord injury (SCI) from a translational neuroanatomical perspective.

Tosolini AP, Morris R.

Neural Regen Res. 2016 May;11(5):743-4. doi: 10.4103/1673-5374.182698. No abstract available.

13.

Segmental distribution of the motor neuron columns that supply the rat hindlimb: A muscle/motor neuron tract-tracing analysis targeting the motor end plates.

Mohan R, Tosolini AP, Morris R.

Neuroscience. 2015 Oct 29;307:98-108. doi: 10.1016/j.neuroscience.2015.08.030. Epub 2015 Aug 22.

PMID:
26304758
14.
15.

Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumours.

Piha-Paul SA, Munster PN, Hollebecque A, Argilés G, Dajani O, Cheng JD, Wang R, Swift A, Tosolini A, Gupta S.

Eur J Cancer. 2015 Sep;51(14):1865-73. doi: 10.1016/j.ejca.2015.06.115. Epub 2015 Jul 18.

16.

A Phase I Trial of Combined Ridaforolimus and MK-2206 in Patients with Advanced Malignancies.

Gupta S, Argilés G, Munster PN, Hollebecque A, Dajani O, Cheng JD, Wang R, Swift A, Tosolini A, Piha-Paul SA.

Clin Cancer Res. 2015 Dec 1;21(23):5235-44. doi: 10.1158/1078-0432.CCR-15-0180. Epub 2015 Jul 17.

17.

A phase 1 clinical trial of vorinostat in combination with decitabine in patients with acute myeloid leukaemia or myelodysplastic syndrome.

Kirschbaum M, Gojo I, Goldberg SL, Bredeson C, Kujawski LA, Yang A, Marks P, Frankel P, Sun X, Tosolini A, Eid JE, Lubiniecki GM, Issa JP.

Br J Haematol. 2014 Oct;167(2):185-93. doi: 10.1111/bjh.13016. Epub 2014 Jul 8.

18.

Targeting the motor end plates in the mouse hindlimb gives access to a greater number of spinal cord motor neurons: an approach to maximize retrograde transport.

Mohan R, Tosolini AP, Morris R.

Neuroscience. 2014 Aug 22;274:318-30. doi: 10.1016/j.neuroscience.2014.05.045. Epub 2014 Jun 2.

PMID:
24892760
19.
20.

Spatial characterization of the motor neuron columns supplying the rat forelimb.

Tosolini AP, Morris R.

Neuroscience. 2012 Jan 3;200:19-30. doi: 10.1016/j.neuroscience.2011.10.054. Epub 2011 Nov 4.

PMID:
22100785
21.

Impaired arpeggio movement in skilled reaching by rubrospinal tract lesions in the rat: a behavioral/anatomical fractionation.

Morris R, Tosolini AP, Goldstein JD, Whishaw IQ.

J Neurotrauma. 2011 Dec;28(12):2439-51. doi: 10.1089/neu.2010.1708. Epub 2011 Aug 12.

PMID:
21612320
22.

Plasma acid-base changes in chronic renal failure: a Stewart analysis.

Story DA, Tosolini A, Bellomo R, Leblanc M, Bragantini L, Ronco C.

Int J Artif Organs. 2005 Oct;28(10):961-5.

PMID:
16288433
23.

Nephrotic range proteinuria in a renal transplant associated with oncocytoma of the native kidney.

Lian M, Mulley W, Kan K, MacGregor D, Tosolini A, Ierino F.

Nephrol Dial Transplant. 2004 Feb;19(2):482-5. No abstract available.

PMID:
14736980
24.

Cryptic t(1;12)(q44;p13.3) translocation in a previously described syndrome with polymicrogyria, segregating as an apparently X-linked trait.

Zollino M, Colosimo C, Zuffardi O, Rossi E, Tosolini A, Walsh CA, Neri G.

Am J Med Genet A. 2003 Feb 15;117A(1):65-71.

PMID:
12548742
25.

Association of Lbc Rho guanine nucleotide exchange factor with alpha-catenin-related protein, alpha-catulin/CTNNAL1, supports serum response factor activation.

Park B, Nguyen NT, Dutt P, Merdek KD, Bashar M, Sterpetti P, Tosolini A, Testa JR, Toksoz D.

J Biol Chem. 2002 Nov 22;277(47):45361-70. Epub 2002 Sep 20.

26.

SV40 infection induces telomerase activity in human mesothelial cells.

Foddis R, De Rienzo A, Broccoli D, Bocchetta M, Stekala E, Rizzo P, Tosolini A, Grobelny JV, Jhanwar SC, Pass HI, Testa JR, Carbone M.

Oncogene. 2002 Feb 21;21(9):1434-42.

27.

Cyclin T2a gene maps on human chromosome 2q21.

De Luca A, Tosolini A, Russo P, Severino A, Baldi A, De Luca L, Cavallotti I, Baldi F, Giordano A, Testa JR, Paggi MG.

J Histochem Cytochem. 2001 Jun;49(6):693-8.

PMID:
11373316
28.

Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1-24.1.

Balsara BR, Pei J, De Rienzo A, Simon D, Tosolini A, Lu YY, Shen FM, Fan X, Lin WY, Buetow KH, London WT, Testa JR.

Genes Chromosomes Cancer. 2001 Mar;30(3):245-53. Review.

PMID:
11170281
29.

Analysis of the structure and expression pattern of MRP7 (ABCC10), a new member of the MRP subfamily.

Hopper E, Belinsky MG, Zeng H, Tosolini A, Testa JR, Kruh GD.

Cancer Lett. 2001 Jan 26;162(2):181-91.

PMID:
11146224
30.

Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity.

Bocchetta M, Di Resta I, Powers A, Fresco R, Tosolini A, Testa JR, Pass HI, Rizzo P, Carbone M.

Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10214-9.

31.
32.

Genitourinary sarcoidosis.

Tosolini AB, Dawborn JK, Sinclair R.

Aust N Z J Med. 1999 Apr;29(2):285-6. No abstract available.

PMID:
10342038
33.

"Tandem" duplication of 4p16.1p16.3 chromosome region associated with 4p16.3pter molecular deletion resulting in Wolf-Hirschhorn syndrome phenotype.

Zollino M, Wright TJ, Di Stefano C, Tosolini A, Battaglia A, Altherr MR, Neri G.

Am J Med Genet. 1999 Feb 19;82(5):371-5.

PMID:
10069706

Supplemental Content

Loading ...
Support Center